CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
Sep. 30, 2012	Sep. 30, 2011
Cash flows from operating activities:
Net income	$ 35,011	$ 24,476
Adjustments to reconcile net income to net cash provided by operating activities:
Provision (credit) for loan and lease losses	(16,602)	(29,475)
Depreciation and amortization	4,760	5,591
Write down of assets	2,586	4,624
Write down of other real estate, net of gain on sale	3,032	(1,220)
Amortization and impairment of other intangible assets	7,490	4,885
Net amortization of investment securities	11,764	5,630
Share-based compensation	2,509	2,171
Net gain on investment securities	(789)	(261)
Net gain on sales of residential loans	(11,084)	(4,380)
Proceeds from sales of loans held for sale	675,799	417,745
Originations of loans held for sale	(650,920)	(422,756)
Equity in earnings of unconsolidated subsidiaries	(386)	(301)
Increase in cash surrender value of bank-owned life insurance	(4,203)	(1,708)
Net change in other assets and liabilities	(16,279)	4,603
Net cash provided by operating activities	42,688	9,624
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	315,723	267,762
Proceeds from sales of investment securities available for sale	130,076	5,324
Purchases of investment securities available for sale	(457,041)	(1,027,233)
Proceeds from maturities of and calls on investment securities held to maturity	689	1,565
Purchases of investment securities held to maturity	(163,498)
Net loan principal repayments (loan originations)	(58,467)	55,815
Proceeds from sales of loans originated for investment	10,340	26,721
Proceeds from sale of other real estate	14,960	34,233
Proceeds from bank-owned life insurance	1,997	158
Purchases of premises and equipment	(2,770)	(706)
Distributions from unconsolidated subsidiaries	455	522
Proceeds from redemption of FHLB stock	434
Net cash used in investing activities	(207,102)	(635,839)
Cash flows from financing activities:
Net increase in deposits	178,062	215,086
Repayments of long-term debt	(50,013)	(201,170)
Net decrease in short-term borrowings	(34)	(201,256)
Net proceeds from issuance of common stock and stock option exercises		322,677
Net cash provided by financing activities	128,015	135,337
Net decrease in cash and cash equivalents	(36,399)	(490,878)
Cash and cash equivalents at beginning of period	257,072	790,739
Cash and cash equivalents at end of period	220,673	299,861
Cash paid during the period for:
Interest	4,489	16,055
Income taxes	1	8
Cash received during the period for:
Income taxes	396
Supplemental disclosure of noncash investing and financing activities:
Net change in common stock held by directors' deferred compensation plan	27	(16)
Net reclassification of loans to other real estate	2,973	38,226
Net reclassification of loans held for sale to other real estate	716
Net transfer of loans to loans held for sale	1,487	1,225
Dividends accrued on preferred stock		969
Accretion of preferred stock discount		204
Preferred stock and accrued unpaid dividends converted to common stock		142,988
Common stock issued in exchange for preferred stock and accrued unpaid dividends		$ 56,201

Represents the aggregate expense charged against earnings to allocate the cost of intangible assets and the amount impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.